Structural nucleotide analogs are potent activators/inhibitors of pancreatic β cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs.
about
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear ForceTherapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug DiscoveryRyanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential.
P2860
Structural nucleotide analogs are potent activators/inhibitors of pancreatic β cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Structural nucleotide analogs ...... eir use as antidiabetic drugs.
@en
Structural nucleotide analogs ...... eir use as antidiabetic drugs.
@nl
type
label
Structural nucleotide analogs ...... eir use as antidiabetic drugs.
@en
Structural nucleotide analogs ...... eir use as antidiabetic drugs.
@nl
prefLabel
Structural nucleotide analogs ...... eir use as antidiabetic drugs.
@en
Structural nucleotide analogs ...... eir use as antidiabetic drugs.
@nl
P2093
P50
P356
P1476
Structural nucleotide analogs ...... heir use as antidiabetic drugs
@en
P2093
Diana Conte Camerino
Domenico Tricarico
Fulvio Loiodice
Gianluigi Cannone
Giuseppe Carbonara
Paolo Tortorella
Valentina Cippone
P304
P356
10.1124/JPET.111.185835
P407
P577
2011-10-25T00:00:00Z